Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

27 Sep 2023 Evaluate
Aurobindo Pharma has informed that Auro Vaccines, a wholly owned subsidiary of the Company, has entered into a Licence Agreement with Hilleman Laboratories Singapore, to develop, manufacture and commercialise a pentavalent vaccine candidate used in children vaccination.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..